Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02259582
Title A Study of Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With Non-Squamous Non-Small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors OncoMed Pharmaceuticals, Inc.
Indications

lung non-small cell carcinoma

Therapies

Carboplatin + Pemetrexed Disodium

Demcizumab

Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST